US FDA approves pre-filled version of GSK's shingles vaccine
Shingles is a viral infection that causes a painful rash anywhere on the body and can sometimes lead to serious complications such as long-term nerve pain and vision loss.
The infection is caused by the varicella-zoster virus (VZV), a type of herpes virus that remains in patients' bodies after they have had chickenpox and reactivates years later.
The previous version of GSK's vaccine required a healthcare professional to mix the powdered form of the virus proteins with a liquid that boosts the immune response, before administration.
The new form of Shingrix, which does not require the mixing, was approved based on data that showed both versions were equally effective.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
8 hours ago
- Scottish Sun
Mystery as body of plane passenger who died on US-bound flight VANISHES after being removed from jet
The passenger reportedly suffered a "severe medical emergency" while the flight FLIGHT SHOCK Mystery as body of plane passenger who died on US-bound flight VANISHES after being removed from jet Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A PASSENGER on a flight from Turkey to the United States died mid-air - but officials are uncertain where the body is. The tragic incident occurred on a flight between Istanbul and San Francisco on July 13. Sign up for Scottish Sun newsletter Sign up 3 Interior of an airplane with passengers standing on foot to depart the plane after landing Credit: Getty 3 The body was removed from the plane upon landing in Chicago Credit: Getty 3 The passenger reportedly suffered a "severe medical emergency" while the flight was cruising over Greenland. To start with, the flight was preparing to divert to Keflavik Airport in Iceland after the death. But in the end they decided to not divert away from North American airspace. According to Aviation A2Z, the urgency to land the plane decreases if a passenger suffering a medical emergency has passed away. "Upon entering the airspace over the United States, the crew opted to land at CHICAGO O'HARE (ORD), a major international hub capable of handling emergency landings with adequate medical support and facilities," the outlet reported. It remains unknown what medical emergency the passenger suffered. The body was removed from the plane upon landing in Chicago. This is the point at which responsibility for the corpse should have gone to Cook County Medical Examiner's Office. But medical examiner spokesperson Natalia Derevyanny told SFGATE that they have no record of a body being brought to them from this flight. The office further does not have any cases that match the description of this incident. American Airlines breaks silence on rumors it is canceling 100s of flights in August after travelers left fearing worst Turkish Airlines station manager Ertugrul Gulsen told the New York Post that the flight had diverted to Chicago and that the passenger's remains were subsequently put on a flight to San Fransisco. However, they did not elaborate further. The exact location of the passenger's remains are still unknown. Turkish Airlines was contacted by The Sun for comment. A 2021 study published in The American Journal of Emergency Medicine says that a "death onboard a commercial aircraft is actually quite rare." It comes following a series of aviation related tragedies in recent weeks. On Tuesday, a small plane crashed into a busy highway in northern Italy. Two people tragically died in the fireball when the light aircraft hurtled into the tarmac. A shocking video shows the plane nosediving towards the road before exploding upon impact.
Reuters
9 hours ago
- Reuters
GSK's blood cancer drug gets EU approval
July 24 (Reuters) - The European Union has approved GSK's (GSK.L), opens new tab drug Blenrep to treat relapsed or treatment-resistant forms of a cancer affecting blood plasma cells, the British drugmaker said on Thursday. EU regulators approved Blenrep after phase III trials showed the drug, when used in combination with standard treatments, extended progression-free survival and improved overall survival in patients with relapsed or refractory multiple myeloma, GSK said. The approval comes a day after the U.S. Food and Drug Administration extended its review of the drug as a combination treatment for the same illness. The FDA's panel of independent experts had last week recommended against the drug, citing concerns about previously documented risks of eye-related side effects. The EU approval marks the sixth regulatory nod for Blenrep combinations, with applications still under review across all major markets. The drug delivers a cell-killing agent directly to tumour cells while limiting damage to healthy tissue — unlike conventional chemotherapy. Multiple myeloma is the third most common blood cancer globally and is generally considered treatable but not curable. It affects the immunity-boosting plasma white blood cells.
Reuters
9 hours ago
- Reuters
GSK's blood cancer drug gets EU approval for multiple myeloma
July 24 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Thursday the European Union has approved the company's blood cancer drug Blenrep for the treatment of relapsed or refractory multiple myeloma.
